EXPD
37
-5
NWS
46
-2
LMT
62
2
WAT
49
-3
GE
72
5
JNJ
60
-2
LYB
23
-4
SWK
61
-3
JCI
51
-6
TDC
83
-3
FDX
53
-2
LRCX
53
-8
CI
52
3
EMR
65
-8
DD
55
-4
GWW
65
-4
WYNN
34
-3
DUK
50
3
DVA
52
-2
XOM
50
-3
EXPD
37
-5
NWS
46
-2
LMT
62
2
WAT
49
-3
GE
72
5
JNJ
60
-2
LYB
23
-4
SWK
61
-3
JCI
51
-6
TDC
83
-3
FDX
53
-2
LRCX
53
-8
CI
52
3
EMR
65
-8
DD
55
-4
GWW
65
-4
WYNN
34
-3
DUK
50
3
DVA
52
-2
XOM
50
-3
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Nektar Therapeutics Industry Stock Comparison

Sell
39

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$97.25
Seasonality Move:
1.23%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.62
Seasonality Move:
11.58%
Sell
39
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $97.51. The Score for TDIV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.76 Buy
Relative Strength Index (14 RSI): 47.25 Sell
Chaikin Money Flow: -60538 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.61 - 99.79) Buy
Bollinger Bands (100): (92.46 - 100.02) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100 Sell
20-day SMA: 97.13 Buy
50-day SMA: 98.56 Sell
200-day SMA: 88.14 Buy
8-day EMA: 99.47 Sell
20-day EMA: 98.48 Sell
50-day EMA: 95.89 Buy
200-day EMA: 59.89 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):